TD Asset Management
PRNB

TD Asset Management’s Principia Biopharma Inc. Common Stock PRNB Stock Holding History

TD Asset Management’s Portfolio PRNB Stock Details PRNB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-36,990
Closed -$2.21M – 1427
2020
Q2 		$2.21M Buy
36,990
+1,600
+5% +$98.8K ﹤0.01% 855
2020
Q1 		$2.1M Buy
35,390
+2,400
+7% +$140K ﹤0.01% 824
2019
Q4 		$1.81M Buy
32,990
+3,872
+13% +$145K ﹤0.01% 949
2019
Q3 		$822K Buy
29,118
+1,200
+4% +$44K ﹤0.01% 1092
2019
Q2 		$927K Buy
27,918
+700
+3% +$21.9K ﹤0.01% 1066
2019
Q1 		$925K Sell
27,218
-700
-3% -$22.3K ﹤0.01% 1057
2018
Q4 		$765K Buy
27,918
+325
+1% +$8.38K ﹤0.01% 1124
2018
Q3 		$806K Buy
+27,593
New +$779K ﹤0.01% 1200

Other funds holding PRNB

Ohio Public Employees Retirement System (OPERS)
Ohio Public Employees Retirement System (OPERS) Columbus, Ohio $34B AUM 40.73% 1-Year Est. Return
Simplex Trading
Simplex Trading Chicago, Illinois $171B AUM 85% 1-Year Est. Return
Skandinaviska Enskilda Banken (SEB)
Skandinaviska Enskilda Banken (SEB) Stockholm, Sweden $2.66B AUM 26.2% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return
Public Employees Retirement Association of Colorado
Public Employees Retirement Association of Colorado Denver, Colorado $28.9B AUM 44.1% 1-Year Est. Return
AB
Amalgamated Bank New York $14.5B AUM 44.3% 1-Year Est. Return
GT
Glenmede Trust Philadelphia, Pennsylvania $22.7B AUM
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
ADL
Asset Dedication LLC San Francisco, California $1.59B AUM 26.56% 1-Year Est. Return

TD Asset Management's PRNB Position: Q3 2020 in Review

TD Asset Management sold out of Principia Biopharma Inc. Common Stock (PRNB) in Q3 2020, closing a stake of 36,990 shares — an estimated $2.21M sold.

TD Asset Management first reported a position in PRNB in Q3 2018 and held it in 8 quarters. The position peaked at $2.21M in Q2 2020. 9 funds tracked by Wall St. Rank hold PRNB as of Q3 2020.

  • TD Asset Management reported no remaining Principia Biopharma Inc. Common Stock position as of Q3 2020 after selling out during the quarter.
  • TD Asset Management sold 36,990 Principia Biopharma Inc. Common Stock shares in Q3 2020, an estimated $2.21M.
  • TD Asset Management first reported a position in Principia Biopharma Inc. Common Stock in Q3 2018 and held it in 8 quarters.
  • TD Asset Management's Principia Biopharma Inc. Common Stock position peaked at $2.21M in Q2 2020.
  • 9 funds tracked by Wall St. Rank held Principia Biopharma Inc. Common Stock as of Q3 2020.

Based on TD Asset Management's 13F filing for Q3 2020, filed 10 Nov 2020.